Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort-Reference-Cited by-同舟云学术

Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort

Published:2015-12 Issue:1 Volume:16 Page:
ISSN:2050-6511
Container-title:BMC Pharmacology and Toxicology
language:en
Short-container-title:BMC Pharmacol Toxicol

Author:

Sagwa Evans L.,Ruswa Nunurai,Mavhunga Farai,Rennie Timothy,Leufkens Hubert G. M.,Mantel-Teeuwisse Aukje K.

Funder

None (self-funded)

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1186/s40360-015-0036-7

Reference44 articles.

1. World Health Organization (WHO). Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: Switzerland; 2008.

2. Ministry of Health and Social Services (MoHSS). National Guidelines for the Management of Tuberculosis. 3rd ed. Windhoek: MoHSS; 2012.

3. Caminero JA, Sotgiu G, Zumla A, Migliori GB. Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. Lancet Infect Dis. 2010;10:621–9. www.thelancet.com/infection Vol 10 September 2010.

4. Brummett RE, Fox KE. Aminoglycoside-induced hearing loss in humans. Antimicrob Agents Chemother. 1989;33:797–800.

5. Cianfrone G, Pentangelo D, Altissimi G, Turchetta R. Pharmacological drugs inducing ototoxicity, vestibular symptoms and tinnitus: a reasoned and updated guide. Eur Rev Med Pharmacol Sci. 2011;15:601–36.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishing multifactorial risk factors for adult-onset hearing loss: A systematic review with topic modelling and synthesis of epidemiological evidence;Preventive Medicine;2024-01

2. Prevalence of long-term physical sequelae among patients treated with multi-drug and extensively drug-resistant tuberculosis: a systematic review and meta-analysis;eClinicalMedicine;2023-03

3. Safety of antituberculosis agents used for multidrug-resistant tuberculosis among patients attending the Jamot Hospital of Yaounde, Cameroon;International Journal of Mycobacteriology;2023

4. Antituberculous Agents for Pediatric Mycobacterial Diseases, and Hearing Loss;Hearing Loss in Congenital, Neonatal and Childhood Infections;2023

5. Reusable molecularly imprinted electrochemiluminescence assay for kanamycin based on ordered mesoporous carbon loaded with indium oxide nanoparticles and carbon quantum dots;Microchimica Acta;2022-10-26